Hanmi Pharmaceutical

14 Wiryeseong-daero, Seoul, Seoul, South Korea

Amosartan XQ

Amosartan XQ

Category[ETC] Cardiovascular
Features The first CCB+ARB+Statin+Ezetimibe fixed-dose combination in the world
Strong blood pressure and LDL-C reducer with excellent tolerability
Indication Applicable to patients taking two or more of the active components of this drug for the treatment of hypertension/dyslipidemia
Active Ingredient Amlodipine + Losartan + Rosuvastatin +Ezetimibe
Strength5 / 50 / 5 /10 mg
5 / 50 / 10 / 10mg
5 / 50 / 20 / 10mg
5 / 100 / 5 / 10 mg
5 / 100 / 10 / 10mg
5 / 100 / 20 / 10mg
Packing30 Tabs
Launched2021.FEB

Technical Specs